Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A4

    
• • ·Editorial Board

    Page :A10

    
• • ·Information for Authors

    Page :A11

    
• • ·Information for Authors

    Page :A12

    
• • ·Information for Readers

    Page :A13

    
• • ·A “STEP” in the right direction

    Page :e31

    Steven M. Lilly

    
• • ·A step towards more ethical prayer studies

    Page :e33

    Peter Hobbins

    
• • ·WATCHMAN: An effective protection against stroke?

    Page :e35

    Claudia Stöllberger, Birke Schneider, Josef Finsterer

    
• • ·Response to letter to the editor by Dr Claudua Stöllberger

    Page :e37

    Rebecca Brown Fountain, David R. Holmes, Krishnaswamy Chandradekaran, Douglas Packer, Samuel Asirvatham, Robert Van Tassel, Zoltan Turi

    
• • ·Letter to the editor by Dr. Adam H. Skolnick

    Page :e39

    Adam H. Skolnick

    
• • ·Controlling the independent variables in the clinical study of prayer: The devil is in the details

    Page :e41

    Eric J. Burks

    
• • ·There is still hope for multifaceted intervention in heart failure

    Page :e43

    Jalal K. Ghali

    
• • ·Authors' reply

    Page :e45

    Nancy M. Allen LaPointe, Judith M. Kramer

    

• Editorial

  • ·Acute coronary syndromes in young patients with angiographically normal coronary arteries

    Page :607-610

    Lloyd W. Klein

    
  • ·Potential for improving sensitivity for detection of old myocardial infarction using the Q wave equivalent criteria in the Selvester QRS scoring system

    Page :611-612

    Galen S. Wagner

    

• Curriculum in Cardiology

  • ·Broken bodies, broken hearts? Limitations of the trauma system as a model for regionalizing care for ST-Elevation Myocardial Infarction in the United States

    Page :613-618

    Brahmajee K. Nallamothu, Paul A. Taheri, William G. Barsan, Eric R. Bates

    Résumé Résumé Plan Plan  
  • ·Left bundle-branch block artifact on single photon emission computed tomography with technetium Tc 99m (Tc-99m) agents: Mechanisms and a method to decrease false-positive interpretations

    Page :619-626

    John P. Higgins, Gethin Williams, James S. Nagel, Johanna A. Higgins

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)

    Page :627-635

    Stephen D. Wiviott, Elliott M. Antman, C. Michael Gibson, Gilles Montalescot, Jeffrey Riesmeyer, Govinda Weerakkody, Kenneth J. Winters, Jeffrey W. Warmke, Carolyn H. McCabe, Eugene Braunwald, for the TRITON-TIMI 38 Investigators

    Résumé Résumé Plan Plan  
  • ·Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: Rationale and design of the Defibrillator After Primary Angioplasty (DAPA) Trial

    Page :636-640

    Jan Paul Ottervanger, Anand R. Ramdat Misier, Felix Zijlstra, Martin J. Schalij, Eric Wever, Luc J.L.M. Jordaens, Jose P.S. Henriques, Menko-Jan de Boer, Hindrik W.J. Robbe, Hein J.J. Wellens, for the DAPA Investigators

    Résumé Résumé Plan Plan

• Clinical Investigations

  • ·Prevalence, predictors, and outcomes of patients with non–ST-segment elevation myocardial infarction and insignificant coronary artery disease: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative

    Page :641-647

    Manesh R. Patel, Anita Y. Chen, Eric D. Peterson, L. Kristin Newby, Charles V. Pollack, Ralph G. Brindis, C. Michael Gibson, Neal S. Kleiman, Jorge F. Saucedo, Deepak L. Bhatt, W. Brian Gibler, E. Magnus Ohman, Robert A. Harrington, Matthew T. Roe

    Résumé Résumé Plan Plan
  • ·The impact of emergency department structure and care processes in delivering care for non–ST-segment elevation acute coronary syndromes

    Page :648-660

    Rajendra H. Mehta, L. Kristin Newby, Yogin Patel, James W. Hoekstra, Chadwick D. Miller, Anita Y. Chen, Barbara L. Lytle, Deborah B. Diercks, Richard L. Summers, Gerard X. Brogan, W. Frank Peacock, Charles V. Pollack, Matthew T. Roe, Eric D. Peterson, E. Magnus Ohman, W. Brian Gibler, for the CRUSADE Investigators

    Résumé Résumé Plan Plan  
  • ·Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks

    Page :661-667

    Ivan C. Rokos, David M. Larson, Timothy D. Henry, William J. Koenig, Marc Eckstein, William J. French, Christopher B. Granger, Matthew T. Roe

    Résumé Résumé Plan Plan  
  • ·Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial

    Page :668-675

    C. Michael Gibson, Ajay J. Kirtane, Sabina A. Murphy, Steve Rohrbeck, Venu Menon, Jeffrey Lins, Samer Kazziha, Ivan Rokos, Nicolas W. Shammas, Theresa M. Palabrica, Polly Fish, Carolyn H. McCabe, Eugene Braunwald, for the TIMI Study Group

    Résumé Résumé Plan Plan  
  • ·Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes

    Page :676-683

    Raymond T. Yan, Andrew T. Yan, Mary Tan, Darren K. McGuire, Lawrence Leiter, David H. Fitchett, Claude Lauzon, Kevin Lai, Chi-Ming Chow, Anatoly Langer, Shaun G. Goodman, for the Canadian Acute Coronary Syndrome Registry Investigators

    Résumé Résumé Plan Plan
  • ·Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS

    Page :684.e1

    Peter R. Sinnaeve, Yao Huang, Kris Bogaerts, Alec Vahanian, Jennifer Adgey, Paul W. Armstrong, Lars Wallentin, Frans J. Van de Werf, Christopher B. Granger, on behalf of the ASSENT-3 and ASSENT-3 PLUS investigators

    Résumé Résumé Plan Plan  
  • ·Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: Twelve-month follow-up results

    Page :684.e11

    Saskia L.M.A. Beeres, Jeroen J. Bax, Petra Dibbets-Schneider, Marcel P.M. Stokkel, Willem E. Fibbe, Ernst E. van der Wall, Martin J. Schalij, Douwe E. Atsma

    Résumé Résumé Plan Plan  
  • ·Home defibrillation: A feasibility study in myocardial infarction survivors at intermediate risk of sudden death

    Page :685.e1

    Tommaso Sanna, Francesco Fedele, Igino Genuini, Andrea Puglisi, Paolo Azzolini, Giuliano Altamura, Francesco Lobianco, Matteo Ruzzolini, Francesco Perna, Mirco Micò, Giancarlo Roscio, Pierluigi Mottironi, Carlo Saraceni, Michele Pistolese, Fulvio Bellocci

    Résumé Résumé Plan Plan  
  • ·Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock—a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry

    Page :686-692

    Raban V. Jeger, Chi-Hong Tseng, Judith S. Hochman, Eric R. Bates

    Résumé Résumé Plan Plan  
  • ·Uvulopalatopharyngoplasty decreases levels of C-reactive protein in patients with obstructive sleep apnea syndrome

    Page :692.e1

    Hiroyuki Kinoshita, Akira Shibano, Takema Sakoda, Hiroki Ikeda, Hiroshi Iranami, Yoshio Hatano, Tadao Enomoto

    Résumé Résumé Plan Plan  
  • ·Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome

    Page :693.e1

    Grant D. Brinkworth, Manny Noakes, Jonathan D. Buckley, Peter M. Clifton

    Résumé Résumé Plan Plan  
  • ·The impact of cardiovascular risk factors on subclinical left main coronary artery disease: An intravascular ultrasound study

    Page :693.e7

    Sang-Wook Kim, Gary S. Mintz, Esteban Escolar, Patrick Ohlmann, Jerzy Pregowski, Pawel Tyczynski, Augusto D. Pichard, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Ron Waksman, Neil J. Weissman

    Résumé Résumé Plan Plan  
  • ·Skin cholesterol adds to Framingham risk assessment

    Page :694-696

    Dennis L. Sprecher, Gregory L. Pearce

    Résumé Résumé Plan Plan  
  • ·Stimulating autoantibodies directed against the cardiac ?₁-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy

    Page :697-704

    Stefan Störk, Valerie Boivin, Rüdiger Horf, Lutz Hein, Martin J. Lohse, Christiane E. Angermann, Roland Jahns

    Résumé Résumé Plan Plan  
  • ·Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction : A retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials

    Page :705-712

    Simon de Denus, Jean-Claude Tardif, Michel White, Martial G. Bourassa, Normand Racine, Sylvie Levesque, Anique Ducharme

    Résumé Résumé Plan Plan  
  • ·Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study

    Page :712.e1

    Alexander Staudt, Astrid Hummel, Jörg Ruppert, Marcus Dörr, Christiane Trimpert, Katrin Birkenmeier, Thomas Krieg, Yvonne Staudt, Stephan B. Felix

    Résumé Résumé Plan Plan  
  • ·Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results of the randomized trial

    Page :713.e1

    Romuald Wojnicz, Jolanta Nowak, Bo?ena Szygu?a-Jurkiewicz, Krzysztof Wilczek, Andrzej Lekston, Przemys?aw Trzeciak, Ewa Nowalany-Kozielska, Marian Zembala, Jan Wodniecki, Lech Polo?ski

    Résumé Résumé Plan Plan  
  • ·The effect of altering heart rate on ventricular function in patients with heart failure treated with ?-blockers

    Page :713.e9

    Simon D.R. Thackray, Justin M. Ghosh, Graham A. Wright, Klaus K.A. Witte, Nikolay P. Nikitin, Gerald C. Kaye, Andrew L. Clark, Ann Tweddel, John G.F. Cleland

    Résumé Résumé Plan Plan  
  • ·Survival in octogenarians receiving implantable defibrillators

    Page :714-719

    Bruce A. Koplan, Laurence M. Epstein, Christine M. Albert, William G. Stevenson

    Résumé Résumé Plan Plan  
  • ·Potential applicability and utilization of left atrial appendage occlusion devices in patients with atrial fibrillation

    Page :720-723

    Rebecca Fountain, David R. Holmes, Patricia K. Hodgson, Krishnaswamy Chandrasekaran, Robert Van Tassel, Peter Sick

    Résumé Résumé Plan Plan  
  • ·A history of heart failure predicts arrhythmia treatment efficacy: Data from the Antiarrythmics versus Implantable Defibrillators (AVID) Study

    Page :724-730

    Michael A. Brodsky, John McAnulty, Douglas P. Zipes, Christina Baessler, Alfred P. Hallstrom, the AVID Investigators

    Résumé Résumé Plan Plan  
  • ·ST-segment abnormalities and premature complexes are predictors of new-onset atrial fibrillation: The Niigata Preventive Medicine Study

    Page :731-735

    Hiroshi Watanabe, Naohito Tanabe, Yashiro Makiyama, Sameer S. Chopra, Yuji Okura, Hiroshi Suzuki, Kazumitsu Matsui, Toru Watanabe, Yoshiaki Kurashina, Yoshifusa Aizawa

    Résumé Résumé Plan Plan  
  • ·The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: A study in 686 consecutive patients

    Page :736-741

    Pascal de Groote, Nicolas Lamblin, Nicole Helbecque, Frédéric Mouquet, Xavier Hermant, Philippe Amouyel, Jean Dallongeville, Christophe Bauters

    Résumé Résumé Plan Plan  
  • ·Lack of sensitivity of the electrocardiogram for detection of old myocardial infarction: A cardiac magnetic resonance imaging study

    Page :742-748

    Federico M. Asch, Sangeeta Shah, Christine Rattin, Srirama Swaminathan, Anthon Fuisz, Joseph Lindsay

    Résumé Résumé Plan Plan  
  • ·The prognostic value of the mitral diastolic filling velocity ratio for all-cause mortality and cardiovascular morbidity in African Americans: the atherosclerotic Risks in Communities (ARIC) study

    Page :749-755

    Ervin R. Fox, Hui Han, Herman A. Taylor, Ulysses C. Walls, Tandaw Samdarshi, Thomas N. Skelton, Jun Pan, Donna Arnett

    Résumé Résumé Plan Plan
  • ·Measurement of the thickness of the fibrous cap by optical coherence tomography

    Page :755.e1

    Teruyoshi Kume, Takashi Akasaka, Takahiro Kawamoto, Hiroyuki Okura, Nozomi Watanabe, Eiji Toyota, Yoji Neishi, Renan Sukmawan, Yoshito Sadahira, Kiyoshi Yoshida

    Résumé Résumé Plan Plan  
  • ·Association between Thrombolysis In Myocardial Infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: Observations from the Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Antiplatelet and Antithrombotic Agents–Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)

    Page :756-761

    C. Michael Gibson, Ajay J. Kirtane, David A. Morrow, Theresa M. Palabrica, Sabina A. Murphy, Peter H. Stone, Benjamin M. Scirica, Lisa K. Jennings, Howard C. Herrmann, David J. Cohen, Carolyn H. McCabe, Eugene Braunwald, for the TIMI Study Group

    Résumé Résumé Plan Plan  
  • ·A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation

    Page :761.e1

    Peter W. Radke, Hans R. Figulla, Helmut Drexler, Heinrich G. Klues, Andreas Mügge, Sigmund Silber, Werner Daniel, Alexander Schmeisser, Nicolaus Reifart, Wolfgang Motz, Hans-Joachim Büttner, Dieter Fischer, Jan R. Ortlepp, Kerstin Schaefers, Rainer Hoffmann, Peter Hanrath, for the AACHEN Trial Investigators

    Résumé Résumé Plan Plan
  • ·Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: Importance of the bifurcation angle

    Page :762-769

    Vladimir Dzavik, Rajesh Kharbanda, Joan Ivanov, Douglas J. Ing, Sanh Bui, Karen Mackie, Rachael Ramsamujh, Alan Barolet, Leonard Schwartz, Peter H. Seidelin

    Résumé Résumé Plan Plan  
  • ·Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: Results from the Cilostazol for RESTenosis (CREST) trial

    Page :770-776

    Zefeng Zhang, Jovonne K. Foster, Paul Kolm, Claudine T. Jurkovitz, Karen M. Parker, Nancy V. Murrah, Grant T. Anderson, John S. Douglas, William S. Weintraub

    Résumé Résumé Plan Plan  
  • ·Correction

    Page :776

    
  • ·Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy

    Page :777-784

    Marianne Ulcickas Yood, Bruce D. McCarthy, Judy Kempf, Gena P. Kucera, Karen Wells, Susan Oliveria, Paul Stang

    Résumé Résumé Plan Plan  
  • ·Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina

    Page :785-792

    Alain G. Bertoni, Denise E. Bonds, Susan Steffes, Eric Jackson, Lenore Crago, Aarthi Balasubramanyam, Haiying Chen, David C. Goff

    Résumé Résumé Plan Plan  
  • ·Response of high-sensitivity C-reactive protein to exercise training in an at-risk population

    Page :793-800

    Kim M. Huffman, Gregory P. Samsa, Cris A. Slentz, Brian D. Duscha, Johanna L. Johnson, Connie W. Bales, Charles J. Tanner, Joseph A. Houmard, William E. Kraus

    Résumé Résumé Plan Plan  
  • ·Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts

    Page :801-806

    Rajendra H. Mehta, Emily Honeycutt, Linda K. Shaw, Donald Glower, Robert A. Harrington, Michael H. Sketch

    Résumé Résumé Plan Plan